公开查询

医疗器械登记 ANVISA 数据

按编号、产品、持有人企业或 CNPJ 查询。数据来自 ANVISA 开放数据,每日更新。

47,540 记录

产品注册持有人企业类别有效性
ANTI-CARDIOLIPINA ELISA IgA EA 1621-9601 A10338930044EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAII当前有效
ANTI-CARDIOLIPINA ELISA IgG EA 1621-9601 G10338930046EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAII当前有效
ANTI-CARDIOLIPINA IGG/IGM10300390661VYTTRA DIAGNOSTICOS S.A.II当前有效
ANTI-CARDIOLIPINA IgA10300390697VYTTRA DIAGNOSTICOS S.A.II当前有效
ANTI-CARDIOLIPINA SCREEN ELISA10300390695VYTTRA DIAGNOSTICOS S.A.II当前有效
ANTI-CELULA PARIETAL10300390706VYTTRA DIAGNOSTICOS S.A.II当前有效
ANTI-CENTROMERO B10300390703VYTTRA DIAGNOSTICOS S.A.II当前有效
ANTI-DNA ENZIMAIMUNOENSAIO10322610028KIMENZ EQUIPAMENTOS LTDAII当前有效
ANTI-DNA TEST KIT (Crithidia luciliae substrate)80016880011NEWLEAF MEDICAMENTOS E DIAGNOSTICO LTDAII当前有效
ANTI-ENA POOL PLUS ELISA (IgG)10338930061EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAII当前有效
ANTI-ESTREPTOLISINA O80615950262Diagmaster Científica ltdaII当前有效
ANTI-ESTREPTOLISINA O A25/A15 TURBIDIMETRIA (ASO)10300390266VYTTRA DIAGNOSTICOS S.A.II当前有效
ANTI-ESTREPTOLISINA O BA400 TURBIDIMETRIA80367750094BIOSYSTEMS NE COMÉRCIO DE PRODUTOS LABORATORIAIS E HOSPITALARES LTDAII当前有效
ANTI-GLIADINA GAF-3X ELISA IGG EV3011-9601 G10338930042EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAII当前有效
ANTI-GLIADINA GAF-3X ELISA IgA EV3011-9601 A10338930045EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAII当前有效
ANTI-GLIADINA IGA10300390604VYTTRA DIAGNOSTICOS S.A.II当前有效
ANTI-GLIADINA IGG10300390805VYTTRA DIAGNOSTICOS S.A.II当前有效
ANTI-INSULINA10300390602VYTTRA DIAGNOSTICOS S.A.II当前有效
ANTI-JO110300390554VYTTRA DIAGNOSTICOS S.A.II当前有效
ANTI-MCV10300390563VYTTRA DIAGNOSTICOS S.A.II当前有效
ANTI-NUCLEOSSOMA10300390680VYTTRA DIAGNOSTICOS S.A.II当前有效
ANTI-PR310300390804VYTTRA DIAGNOSTICOS S.A.II当前有效
ANTI-RIB P10300390835VYTTRA DIAGNOSTICOS S.A.II当前有效
ANTI-SCL-70 ELISA IgG EA 1599-9601 G10338930051EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAII当前有效
ANTI-SCL7010300390678VYTTRA DIAGNOSTICOS S.A.II当前有效

来源为 ANVISA 医疗健康产品开放数据。该数据提供注册有效期,并不反映完整登记状态;注册可能在到期前已被注销,而此处未显示。决定购买、进口或销售前,请核对 ANVISA 官方查询门户.

接下来的步骤

您的产品需要在巴西注册

HSC 支持医疗器械 ANVISA 注册,从风险分类到申报进度跟踪。

联系专家